- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Princeton University
Headquarters: Princeton, NJ, United States
Website: http://princeton.edu
Year Founded: 1746
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Apr 10, 2025
Politics, Policy & Law
As more NIH cuts loom, researchers warn U.S. science at risk
In addition to obvious blows, unseen damage could be lasting, NIH staff caution
BioCentury | Dec 6, 2024
Emerging Company Profile
Disco: Mapping protein communities on cancer cell surfaces
German biotech has already mapped small cell lung cancer surface proteins, colorectal is next
BioCentury | Jun 21, 2024
Finance
Venture Report: Syncona’s backs a pair of biotechs; Marea makes debut with $190M
Plus: Forbion’s new sustainability fund, and rounds for Elion, ashibio, NephroDI and Ability
BioCentury | Apr 6, 2024
Discovery & Translation
Science spotlight: Three strategies for enhanced genome editing, plus Mapp’s Nipah virus mAb
BioCentury’s roundup of translational innovations
BioCentury | Dec 21, 2023
Management Tracks
Larson leaving LianBio as CFO
Plus: Claypoole becomes CEO of Bioventus, and updates from Boston Pharma, Atlas, Quest, Scribe, 858 and more
BioCentury | Sep 16, 2022
Finance
Sept. 15 Quick Takes: Khosla seeds Cas13 company Carver
Plus RGImmune launches with F-Prime’s backing and updates from Pfizer, Tridek-One
BioCentury | Feb 16, 2022
Emerging Company Profile
Splice Bio: gene therapies that reassemble large proteins in vivo
Spain’s largest-ever biotech series A goes to Ysios-backed Splice Bio, which uses inteins to reconstitute large proteins
BioCentury | Oct 29, 2021
Discovery & Translation
Omics-based target identification in UK Biobank and COVID-19 cohorts
Plus: technologies from Harvard, Texas A&M, Disney lab and more
BioCentury | Oct 8, 2021
Product Development
Oct. 7 Quick Takes: Early POC data for Bicycle buoys shares
Plus FDA backs Takeda’s maribavir, RA’s $880M fund and updates from AbbVie, Turning Point, EQRx and more
Items per page:
1 - 10 of 114